Long joint hearing exposes deep split over multiple cannabis bills, from low‑dose hemp rules to an adult‑use framework

A joint session of the Hawaii State Senate Commerce and Consumer Protection and Health committees on Feb. 17 hosted extended testimony on a suite of cannabis bills, producing sharp divisions among public‑health officials, law‑enforcement, educators, industry and civil‑liberties advocates.

Deputy Attorney General Alana Bryant and Department of Health representatives told lawmakers the bills should align with shifting federal law and include strong public‑health safeguards. Bryant recommended that any adult‑use legalization tied to federal triggers not take effect until 18 months after a trigger to allow preparations by law enforcement and the public. Andrew Goff of the Office of Medical Cannabis Control and Regulation repeatedly emphasized technical constraints: the state's seed‑to‑sale tracking system requires a registration number to track purchases, which complicates proposals allowing immediate purchases before registry approval.

SB 3206 would allow certain hemp‑derived products at a potency limit of 5 milligrams of THC per serving. Supporters argued the limit would let Hawaii farmers sell product in‑state without costly remediation; opponents, including educators and prosecuting attorneys, warned that the bill fails to define "serving" and would make THC products easy to disguise on school campuses. The prosecuting attorney's office said the bill’s serving‑size language is vague for tinctures and flower and flagged constitutional risks.

SB 3315 would permit a one‑time purchase (up to two ounces) for patients awaiting medical cannabis registry cards. Advocates and dispensary operators argued registration delays harm patients and suggested system changes (instant or same‑day approvals or dispensary‑specific one‑time purchase tracking) as fixes. DOH representatives said system updates are underway but stressed that registration numbers are required for reliable tracking.

SB 2421, a framework bill that would create a state regulatory body and condition adult‑use commercialization on one of three triggers (federal legalization, presidential descheduling, or a state constitutional amendment), drew the largest turnout. Supporters urged the legislature to adopt a regulatory framework and drop conditional triggers; opponents, including the Honolulu prosecuting attorney and police leadership, urged deferral or rejection citing impaired driving, youth access, and community harms. The chair summarized the day's registered testimony tally as 17 in support, 44 in opposition, and 10 offering comments.

Across hearings, witnesses recommended clearer statutory definitions (for serving sizes and potency thresholds), stronger age‑access and marketing safeguards, and technical amendments to align state law with pending federal changes due in November 2026. Lawmakers repeatedly asked DOH about what system changes would be required to implement same‑day or one‑time sales while preserving tracking and enforcement.

The committees deferred further action and planned to continue the remaining testimony at a reconvened joint hearing the next day.